Inhibin B and anti‐Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
- 19 October 2004
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 111 (11), 1248-1253
- https://doi.org/10.1111/j.1471-0528.2004.00452.x
Abstract
Objective The objective of this study was to investigate whether follicle stimulating hormone (FSH), anti-Mullerian hormone (AMH) and inhibin B could be useful in predicting the ovarian response to gonadotrophin stimulation in assisted reproduction patients who are considered to be poor responders. Design Prospective study. Setting Fertility unit. Sample Blood samples were collected on day five or six in the early follicular phase of an untreated menstrual cycle. Samples were collected from 69 patients. Methods Serum samples were assayed for FSH, AMH and inhibin B using commercial immunoassay kits. Main outcome measures Response to gonadotrophin stimulation and number of eggs collected. Results Among the 69 patients, 52 patients completed an IVF cycle and 17 patients had to cancel the cycle because of poor ovarian response to gonadotrophin stimulation. Mean FSH levels were significantly higher (P < 0.05) in the cancelled group (10.69 ± 2.27 mIU/mL) compared with the cycle-completed group (7.89 ± 0.78 mIU/mL). Mean AMH levels were significantly lower (P < 0.01) in the cancelled group (0.175 ± 0.04 ng/mL) compared with the cycle-completed group (1.13 ± 0.2 ng/mL). Mean inhibin B levels were significantly lower (P < 0.001) in the cancelled group (70 ± 12.79 pg/mL) compared with the completed group (126.9 ± 8.8 pg/mL). Predictive statistics show that AMH is the best single marker and that the combination of FSH, AMH and inhibin B is modestly better than the single marker. Linear regression analysis in the cycle completed patients shows that although FSH (r= 0.25, P < 0.05) and inhibin B (r= 0.35, P < 0.05) have a significant linear association with the number of eggs collected, AMH has the greatest association (r= 0.69, P < 0.001) with the number of eggs collected among the parameters measured. Conclusion In this particular group of IVF patients, AMH is the best single marker of ovarian response to gonadotrophin stimulation. The combined markers modestly improved the prediction.Keywords
This publication has 25 references indexed in Scilit:
- The role of inhibin B as a basal determinant of ovarian reserveGynecological Endocrinology, 2003
- The role of inhibin B as a basal determinant of ovarian reserveGynecological Endocrinology, 2003
- Antimüllerian hormone serum levels: a putative marker for ovarian agingFertility and Sterility, 2002
- Modulation of Endogenous GATA-4 Activity Reveals Its Dual Contribution to Mullerian Inhibiting Substance Gene Transcription in Sertoli CellsMolecular Endocrinology, 2001
- Serum müllerian-inhibiting substance levels during normal menstrual cyclesFertility and Sterility, 2000
- Targeted Mutagenesis of the Endogenous Mouse Mis Gene PromoterCell, 1999
- Use of the Antral Follicle Count to Predict the Outcome of Assisted Reproductive TechnologiesFertility and Sterility, 1998
- Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor responseHuman Reproduction, 1997
- Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilizationHuman Reproduction, 1997
- Measurement of dimeric inhibin B throughout the human menstrual cycleJournal of Clinical Endocrinology & Metabolism, 1996